Skip to content

A Comparison of Propofol-based Total Intravenous Anesthesia and Desflurane Anesthesia on NK cell Activity After Major Hepatic Resection in Hepatocellular Carcinoma Patients

A Comparison of Propofol-based Total Intravenous Anesthesia and Desflurane Anesthesia on NK cell Activity After Major Hepatic Resection in Hepatocellular Carcinoma Patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210218001
Enrollment
30
Registered
2021-02-18
Start date
2019-10-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-metastatic hepatocellular carcinoma patients requiring major hepatectomy Hepatocellular Carcinoma NK cells activity Anesthetic technique

Interventions

Anesthesia was induced with propofol 1-2 mg/kg of LBW and maintained with propofol target-controlled infusion to 4 mg/ml with the Schnider model.,The anesthetic induction was with 6-8% of sevoflurane
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
Propofol-based TIVA,Desflurane anaesthesia

Sponsors

Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with non-metastatic HCC 2.Aged 18 to 75 years 3.ASA physical status I-III 4.Scheduled for elective major hepatic resection

Exclusion criteria

Exclusion criteria: 1. Unsuccessful epidural catheter insertion for pain control 2. Patients refusal 3. Diagnosed with recurrent HCC before the research participation 4. Known allergy to medications used in the research protocol 5. Severe systemic diseases such as cardiovascular, respiratory, or endocrine system conditions 6. Frequent users of anxiolytics and opioids 7. Addiction to alcohol or drug abuse 8. Psychiatric conditions 9. Immunocompromised or receive immunosuppressive drugs within 6 months 10. Diagnosed with or family history of malignant hyperthermia.

Design outcomes

Primary

MeasureTime frame
NK cell cytotoxicity 24 hour postoperatively laboratory results

Secondary

MeasureTime frame
Interleukin-6 24 hour postoperatively laboratory results,Interleukin-10 24 hour postoperatively laboratory results,Recurrent rate 2 years postoperatively Whole abdominal CT scan

Countries

Thailand

Contacts

Public ContactKirada Apisutimaitri

Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University

kirada.api@gmail.com0814834274

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026